Completed

The University of Arizona is not eligible for this funding opportunity

NIGMS will co-fund applications from higher education institutions that award undergraduate (B.S. or B.A.) and/or graduate degrees in biomedical sciences and have received no more than $6 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER, at the time of the application.  Applications to be considered must support research aligned with the NIGMS mission. Applications for research capacity building in Institutional Development Award (IDeA)-eligible states will be considered.  

Limit: 3 // Tickets Available: 0 

B. Vasic (Electrical and Computer Engineering)
M. Hassan (Physics)
E. Hamden (Space Institute) 

Limiting Language 
We will be accepting up to 3 proposals per university for review

Program Overview
JPL has formal strategic partnerships with 15 universities that have major commitments to space exploration, and broad connections to JPL. The Strategic University Research Partnerships (SURP) program supports these partnerships, providing resources to foster strong collaborative relationships. The program works with JPL researchers and our strategic partners to develop new science and technology opportunities and provide accelerated innovation for NASA’s missions.
 

Limit: 1 // Tickets Available: 0

J. Galgiani (Valley Fever Center for Excellence)

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Funding Opportunity Purpose
The purpose of the notice of funding opportunity (NOFO) is to solicit applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program. This new initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine as outlined in NIAID’s Strategic Plan for Research to Develop a Valley fever Vaccine.

Limit: 1 // Tickets Available: 0 

J. Burgess (Community, Environment and Policy)

Limiting Language
Eligible applicants may submit only one application for each eligible activity under the FP&S Grant Program (one application under the FP&S Activity and/or one application under the R&D Activity). Applications for both activities  may include up to three projects. Eligible Applicants interested in applying under both activities must submit two separate applications – one for each activity. The application questions included in the FP&S Activity are different from those in the R&D Activity application. Submissions of duplicate applications may be disqualified.  

Purpose
FP&S Grant Program supports fire departments and non-profit organizations for fire prevention programs and firefighter health and safety research and development. The FP&S Grant Program is separated into the following two activities: Fire Prevention and Safety (FP&S) and Research and Development (R&D). Using a competitive process that is informed by fire service subject matter experts, the Federal Emergency Management Agency (FEMA) awards grants in both activities to applicants whose requests best address the priorities of the FP&S Grant Program. 

Limit: 3 // Tickets Available: 0

G. Martin-Alemañy (Nutritional Sciences and Wellness)
B. Tanriover (COM-T)
S. Kharait (COM-T)

Limiting Language
A limit of three proposals from each sponsoring academic institution is imposed to enable fair and broad support for DCI-affiliated investigators.

Overview 
The Paul Teschan Research Fund (PTRF) of Dialysis Clinic, Inc. (DCI) offers grant support for research
related to human kidney disease. Research methods may range from basic science to clinical and
epidemiologic research. Support from this fund, named to honor Paul Teschan, MD, a distinguished
investigator, clinician and advisor to DCI, is intended to promote investigations of current or eventual clinical
significance that might not be able to achieve funding from NIH or other national sources because of their
clinical nature, their early stage of work, or other reasons. The PTRF is a source of funding for worthy
projects where other sources are unavailable.

A limit of three proposals from each sponsoring academic institution is imposed to enable fair and broad
support for DCI-affiliated investigators. Each individual grants are limited to $60,000 per year, including
institutional overhead. The funding period for PTRF research grants is Jan 1 – Dec 31. The initial award
installment is contingent on the project passing DCI’s legal, compliance and regulatory review. This includes
obtaining IRB or IACUC approvals. Subsequent installments are contingent upon adherence to the award
letter.

Preference will be given to earlier research career investigators and to projects considered most relevant
to understanding and treatment of clinical kidney conditions and their complications. All proposals will be
reviewed for scientific merit and significance by external reviewers and also by a panel of DCI-affiliated
nephrologists (Application Review Committee) as part of the competitive application process. Renewal of
ongoing PTRF funding projects is given preference, but is not automatic. Grant awards are merit based.
PTRF grants may not be used to fund salaries of investigators, but may support other personnel active in
the project as approved by DCI. Capital equipment costing $1500 or more may not be included in PTRF
budgets. Overhead is limited to 20% ($10,000). Travel may be requested in the budget during Year 2 and
Year 3 if work from the PTRF project is being presented at a conference, but this may not exceed $1500
per year. No travel will be supported by Year 1 funds. Projects will only be funded for one year at a time
and may be funded for a total of three (3) consecutive years. Year 2 and Year 3 applications will undergo
competitive review by the Application Review Committee for continued funding based on progress
described in a DCI PTRF Study Progress Report. Applications for Year 2 and Year 3 funding will be
reviewed in the same way as an initial application, including reassessment of the scientific merit of the work
proposed as well as the addition of a detailed review of the work accomplished. Grants may not be renewed
in the absence of progress satisfactory reports.

The July 2026 deadline is institutionally coordinated. For more information, please contact RDS. 

The University of Arizona is not eligible due to an existing award: A current recipient or applicant of the NIOSH T03, Occupational Safety and Health Training Project Grants award is not eligible for an award or a sub-award under this Funding Opportunity Announcement.

Limit: 1 // Tickets Available: 0 

K. Huntoon (Neurosurgery)

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate one applicant.

Purpose of Award:

The UACC is seeking nominations for the V Scholar Grant call which supports adult cancer research. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. The V Scholar Grant supports tenure-track faculty in the early stages of their independent cancer research careers. This grant mechanism is designed to advance exceptional early-career investigators at the Assistant Professor level and position them to successfully compete for larger, sustaining grants such as NIH R01 awards or equivalent funding.

Research on ANY adult cancer type will be funded in this call. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Award Amount:

• The total grant award is $800,000 over four years, with annual payments of $200,000. No indirect costs allowed.
• The V Foundation follows NIH Guidelines regarding salary caps. Institutions are welcome to supplement a grant recipient’s salary with institutional funds if desired.  

Applicant Eligibility:

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US.
• Have completed at least two years postdoctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if one year is standard for their specialty
• Clinical scientists must have full institutional support (e.g., dedicated lab space, protected research time, start-up funds).
• Hold a full-time, tenure-track or tenured faculty position (e.g., eligible to apply as PI on an R01 at their institution). Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible.
• Have been appointed to their first full-time, tenure-track Assistant Professor position within five years of the nomination due date and not yet promoted to Associate Professor.
  • Extensions to the five-year limit may be granted on a case-by-case basis for nominees who have taken parental or other qualifying leave during this period.
  • To request approval before submitting the nomination form, email grants@v.org with the following information from your institution:
    • Appointment start date
    • Length and category of leave (e.g., medical, parental)

Limit: 3 // Tickets Available: 2

P. Madhivanan (Public Health)

Limiting Language
Applications are limited to three submissions per institution. Institutions may submit up to three applications for each Impact Grant track (research grants and fellowship projects and community projects). Institutions are defined by distinct EIN numbers. 

Executive Summary 
The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Our mission is empowering people to stay ahead of cancer through prevention and early detection. Our vision is a world where cancer is preventable, detectable and beatable for all.  

To advance the Prevent Cancer Foundation’s bold goal to reduce cancer deaths by 40% by 2035, we aim to support innovative research and vital community projects dedicated to increasing and advancing cancer prevention and early detection.  

The goal of the Prevent Cancer Foundation’s research program is to identify and provide funding for innovative projects with the potential to make substantial contributions to cancer prevention and/or early detection. By funding the most promising research, including fellowship projects led by early-career scientists, we contribute to important advances in cancer prevention and early detection.  

The Foundation funds research grants and fellowships at a broad range of academic institutions and cancer centers across the United States, including both well-established and rising institutions advancing cancer research.